Stay updated on MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.

Latest updates to the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedPublications section now notes that PubMed entries are auto-filled and may not all relate to the study; revision numbers updated to v3.3.2 and v3.2.0.SummaryDifference0.1%

- Check22 days agoChange DetectedThe notice about government funding lapse and NIH Clinical Center operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check37 days agoChange DetectedScreenshots indicate only minor UI/layout changes with no observable modifications to core study content (inclusion criteria, locations, enrollment, or outcome measures). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check66 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference5%

- Check73 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

- Check87 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2; removed the Back to Top element as a minor UI change.SummaryDifference0.3%

Stay in the know with updates to MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.